Sumitomo Dainippon Pharma

May 22, 2019 (PDF/90KB)Products

Sumitomo Dainippon Pharma to Launch RETHIO for Conditioning Treatment Prior to Autologous Hematopoietic Stem Cell Transplantation
May 16, 2019Finances

Posted Video of Investors Meeting Presentation for FY2018 [Webcast]
May 10, 2019 (PDF/608KB)Finances

Presentation Material (Financial Results for FY2018)
May 10, 2019 (PDF/461KB)Finances

Supplementary Financial Data (IFRS) for the Year Ended March 31, 2019
May 10, 2019 (PDF/267KB)Finances

Summary of Consolidated Financial Results for the Year Ended March 31, 2019 [IFRS]

Other Notices

Dec. 03, 2018Others

Posted Factbook 2018 ver.2
Sep. 27, 2018CSR (PDF/179KB)

Sumitomo Dainippon Pharma Selected as a Component of Dow Jones Sustainability Indices (DJSI) for the second Consecutive Year
Sep. 27, 2018CSR (PDF/186KB)

Sumitomo Dainippon Pharma Receives the Award of Gold Class in Overall Category of SUSTAINA ESG AWARD 2018

IR Library